Effects of intravenous diazoxide and chlorpropamide on renal function in man.
D002747:Chlorpropamide / Q000008:administration & dosage* / Q000494:pharmacology; D003681:Dehydration / Q000503:physiopathology; D003919:Diabetes Insipidus / Q000503:physiopathology; D003981:Diazoxide / Q000008:administration & dosage* / Q000494:pharmacology; D004231:Diuresis / Q000187:drug effects; D005919:Glomerular Filtration Rate; D006801:Humans; D006973:Hypertension / Q000503:physiopathology; D006982:Hypertonic Solutions; D007275:Injections, Intravenous; D007668:Kidney / Q000098:blood supply / Q000187:drug effects* / Q000503:physiopathology; D009994:Osmolar Concentration; D011188:Potassium / Q000652:urine; D012039:Regional Blood Flow; D012964:Sodium / Q000652:urine; D012965:Sodium Chloride / Q000008:administration & dosage
D006982:Hypertonic Solutions; D012965:Sodium Chloride; D012964:Sodium; D003981:Diazoxide; D011188:Potassium; D002747:Chlorpropamide